Skip to main content
main-content

01.12.2012 | Research | Ausgabe 1/2012 Open Access

World Journal of Surgical Oncology 1/2012

Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival

Zeitschrift:
World Journal of Surgical Oncology > Ausgabe 1/2012
Autoren:
Xiao-Song Wu, Hong-Qing Xi, Lin Chen
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1477-7819-10-244) contains supplementary material, which is available to authorized users.
Xiao-Song Wu, Hong-Qing Xi contributed equally to this work.

Competing interests

The authors declare they have no competing interests.

Authors’ contributions

XSW participated in the study design, carried out most of the experiments, performed the histological evaluation, and drafted the manuscript; HQX analyzed and interpreted the data, and carried out some of the experiments; LC participated in its design and gave final approval of the version to be published. All authors read and approved the final manuscript.

Abstract

Background

Lgr5 (leucine-rich-repeat-containing G-protein-coupled receptor 5) has recently been identified as an intestinal stem cell marker. In order to determine whether Lgr5 is a potential marker of cancer stem cells, we investigated whether Lgr5 expression correlated with Ki-67 expression and prognosis in colorectal carcinoma.

Methods

Lgr5 and Ki-67 expression were evaluated by immunohistochemistry in 192 colorectal carcinoma specimens. Selection of side population (SP) cells was performed by staining with Hoechest 33342, and Lgr5 expression in Colo205 SP cells was then detected by immunofluorescence.

Results

Lgr5 expression was significantly higher in carcinoma than in normal mucosa (P=0.001). Lgr5 was positively correlated with histological grade (P=0.001), depth of invasion (P=0.001), lymph node metastasis (P=0.001), distant metastasis (P=0.004), pTNM stage (P=0.001), and Ki-67 (r=0.446, P=0.001). Multivariate analysis showed that the effect of Lgr5 on survival was independent of Ki-67 (P=0.037). In the in vitro study, Hoechst low-staining cells were counted in 7% of the Colo205 colon cancer cell line population, and Lgr5 expression was strikingly stronger in Hoechst low-staining cells than in high-staining cells (P=0.001).

Conclusions

These findings suggest that Lgr5 may play an important role in the progression and prognosis of colorectal carcinoma, and may be a potential new therapeutic target for the treatment of colorectal cancer patients. It may also be considered as a potential marker for colorectal cancer stem cells (CSCs).
Zusatzmaterial
Authors’ original file for figure 1
12957_2012_1140_MOESM1_ESM.jpeg
Authors’ original file for figure 2
12957_2012_1140_MOESM2_ESM.jpeg
Authors’ original file for figure 3
12957_2012_1140_MOESM3_ESM.jpeg
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2012

World Journal of Surgical Oncology 1/2012 Zur Ausgabe

Neu im Fachgebiet Chirurgie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Chirurgie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise